We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DOJ Sides With Sandoz in SCOTUS Case Leftovers Against Amgen
DOJ Sides With Sandoz in SCOTUS Case Leftovers Against Amgen
The U.S. government sided with Sandoz on the residual claims from the biosimilar manufacturer’s Supreme Court case with Amgen — arguing the federal law outlining the biosimilar approval process should preempt state laws on the topic.